Prednisone for Chronic Active Liver Disease: Pharmacokinetics, Including Conversion to Prednisolone
- 1 May 1977
- journal article
- research article
- Published by Elsevier in Gastroenterology
- Vol. 72 (5) , 910-913
- https://doi.org/10.1016/s0016-5085(77)80209-6
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- BEHAVIOUR OF e ANTIGEN AND ANTIBODY DURING CHRONIC ACTIVE LIVER DISEASE RELATION TO HB ANTIGEN-ANTIBODY SYSTEM AND PROGNOSISThe Lancet, 1976
- Prednisone for chronic active liver disease: dose titration, standard dose, and combination with azathioprine compared.Gut, 1975
- Clinical PharmacokineticsNew England Journal of Medicine, 1975
- Decreased Clearance of Prednisolone, a Factor in the Development of Corticosteroid Side EffectsJournal of Clinical Endocrinology & Metabolism, 1974
- CONTROLLED TRIAL OF PREDNISONE AND AZATHIOPRINE IN ACTIVE CHRONIC HEPATITISThe Lancet, 1973
- Corticosteroids in liver disease: Studies on the biological conversion of prednisone to prednisolone and plasma protein bindingGut, 1972
- Adverse Effects of Phenobarbital on Corticosteroid Metabolism in Patients with Bronchial AsthmaNew England Journal of Medicine, 1972
- Conversion of cortisone to cortisol and prednisone to prednisolone.BMJ, 1967
- THE METABOLISM OF CORTISOL BY HUMAN EXTRA-HEPATIC TISSUESJournal of Endocrinology, 1966
- Metabolism of 11-oxygenated steroids. 3. Some 1-dehydro and 9α-fluoro steroidsBiochemical Journal, 1964